Peter is co-founder and CEO of Aureum and has been involved in the Danish medicinal cannabis industry from the beginning. Peter has professional experience in finance and accounting with global shipping company A.P. Moller Maersk, at both group level and in the tanker industry. Peter started working in business development within the medical cannabis industry at Medican, which later led to the establishment of Aureum.
Inge-Lise Hassing is a high-performance pharmacists with extensive hands-on experience in the pharmaceutical industry. Inge-Lise has been responsible for tablet production and GMP compliance as Production Manager at Takeda Nycomed. After having been stationed in China for 5 years, Inge-Lise returned to Denmark as Senior Consultant and delegate QP for AlfaNordic. Since medicinal cannabis was legalized in Denmark, Inge-Lise have worked closely with some of the largest LP’s advising on implementation and GMP compliance.
Henriette Dahlgaard has 20+ years of
experience from the pharmaceutical industry
hereof 18 years in Quality Assurance and 4
years in validation. Henriette has a proven
track record in building Quality Management
Systems, establishing and executing validation
masterplans to hosting and performing
inspections. Henriette have a broad
experience in each stage of a product lifecycle,
a wide range of product types and
manufacturing on a global scale. Latest
Henriette has worked as Director of R&D and
Regions Quality at LEO Pharma QA, Alfa
Nordic and Canopy Growth Denmark.
Board of Directors
Mike counsels Danish and International companies within most areas of corporate law. He also advises on leadership, strategy and finance. Mike conducts litigation and arbitration proceedings for all court instances in Denmark. In addition, Mike has procedural experience from the European Court of Justice. Mike is a lawyer and partner at Mortang Advokater.
Farzad is an innovative leader with 25 years of experience in the pharma industry. Farzad has held various senior positions in international companies such as Novo Nordisk, Hoffman-La Roche and Orion Pharma. Farzad has a proven track record of developing and implementing marketing strategies, product launches and business development. Farzad is Chief Executive Officer at Medican A/S.
Nelson is a Managing Partner of GreenField Global Opportunities Fund, responsible for international operations. Together with his team of experts, Nelson manages a diversified portfolio of investments within the global cannabis industry. Nelson is an experienced entrepreneur and founder of GeneSeas, which became South Americas largest tilapia farming and processing operation.
Contact us today to learn more about our processes and services.